{"version":"1.0","type":"rich","provider_name":"Tech & Business","provider_url":"https://techandbusiness.org","title":"O'Melveny Represents Leading Medical Imaging AI Company Diagens Biotechnology in US$101 Million Hong Kong IPO","author_name":"T&B Newswire · Startups","thumbnail_url":"https://www.omm.com/media/stcayulx/meta_omm_hero_image.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;text-transform:uppercase;\">T&B NEWSWIRE · Startups</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/dwShKCC5FBZlnWiQ1PrMZG\" style=\"color:#fff;text-decoration:none;\">O'Melveny Represents Leading Medical Imaging AI Company Diagens Biotechnology in US$101 Million Hong Kong IPO</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">O'Melveny represented Hangzhou Diagens Biotechnology Co., Ltd., known as Diagens, in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. The total offering size ...</p>\n    </blockquote>"}